| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.32 | 3e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.34 | 4e-09 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-09 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-09 |